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Abstracts 27 
Objective: To evaluate effectiveness and safety of debulking and diode laser photocoagulation 28 
(DPC) for the treatment of limbal melanomas (LMs). 29 
Animal studied: Twenty dogs (12 females and 8 males) and 1 cat were included in this study. The 30 
dogs’ average age was 5 years (range: 7 months to 12 years).  31 
Procedure: Retrospective multi-institutional case series. Medical records of animals diagnosed 32 
with LM at the Centro Veterinario Specialistico (CVS) and at the Long Island Veterinary Specialists 33 
from 1994 to 2013 were retrieved. Signalment, location, extent of tumors, recurrence rate, and early 34 
and late complications were reported. Patient follow-up information was obtained from veterinary 35 
ophthalmologists, primary care veterinarians, and, when appropriate, owners. 36 
Results: The follow-up period ranged from 1 to 72 months after the surgery. Long-term follow-up 37 
was obtained by telephone interviews in 6/21 cases and by clinical re-evaluations in 15/21 cases. 38 
The most common early complications were a moderate anterior uveitis peripheral corneal edema 39 
(21/21 eyes). Late complications included corneal fibrosis and/or pigmentation (21/21). In one case, 40 
a severe bullous keratopathy associated with an extended corneal fibrosis was observed. The vision 41 
was maintained in 19 eyes (19/21). 42 
Conclusions: Debulking associated with diode laser photocoagulation was technically 43 
straightforward to perform, minimally invasive, well-tolerated and highly successful in this case 44 
series.  45 
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INTRODUCTION 53 
Melanocytic tumors represent the most common ocular tumors in small animals and seem to occur 54 
more commonly in dogs than in cats.1-3 Melanocytic neoplasias may be classified according to the 55 
involved ocular structures [intraocular melanoma (localized in the anterior uvea, and choroid) or 56 
limbal melanoma]. Epibulbar or limbal melanomas (LMs) represent 10-34% of all canine 57 
melanocytic ocular tumors, and they are recognized as solid and circumscribed masses arising in the 58 
sclera or subconjunctival connective tissue at the limbus.4-5 These masses are characterized by 59 
strong pigmentation, but they can occasionally be amelanotic.6 LMs originate from melanocytes of 60 
the corneoscleral junction and have slow growth in sclera, corneal stroma and conjunctival tissue.5,7-61 
9  62 
Predisposing factors for limbal melanomas are scattered throughout the literature. Highly 63 
pigmented dogs seem to be more predisposed to developing LM.9 Several studies have confirmed a 64 
high incidence of this tumor in breeds such as the German Shepherd, Labrador Retriever, and 65 
Golden Retriever.6,9-11 Previous reports suggested that LM, anterior uveal melanoma and ocular 66 
melanosis are presumed to be hereditary in Golden and Labrador Retrievers and that the same 67 
genetic mutation may be associated with melanocytic disease at different ocular sites.9 The 68 
difference in the incidence of LM between sexes is currently considered irrelevant.5,8,9,11 With 69 
regard to anatomical sites, although the LM can develop anywhere on the limbus, the dorsolateral 70 
quadrant is the most frequently affected site.5,6,8-10 71 
The most frequent primary intraocular tumor in cats is a malignant melanoma of the anterior 72 
uvea.12,13 In the literature, a few cases of LMs are reported in cats.14,15 LM occurs more often in 73 
older cats15 but can also affect younger cats.16-18 In contrast to dogs, metastasizing melanomas of 74 
the limbus have been reported in cats.16,17,19  75 
Surgical management is currently considered the treatment of choice in the case of limbal 76 
melanomas in dogs and cats. In dogs, LMs are slowly progressive benign tumors.5,2 Nevertheless, 77 
their growth may be locally invasive, and their extensions can impair vision and compromise the 78 
internal structures of the globe.5,6,9,10 In the past, surgical management was advised in young dogs, 79 
whereas in older dogs, periodic surveillance was considered satisfactory.6,10 This practice was based 80 
upon two retrospective studies in which limbal melanomas had different biological behavior at 81 
different ages, with younger dogs (2-4 years-old) developing more invasive melanomas than older 82 
dogs (8 to 11 years old).6,10 A recent report demonstrated that growth rate of limbal melanomas is 83 
faster in older animals compared to younger ones.9 This has led to a change in current clinical 84 
recommendations, with current recommendations suggesting a more aggressive surgical treatment 85 
should be pursued, regardless of the age of the animal. Several surgical techniques for treatment of 86 
LMs were described in the literature, including a full thickness en bloc resection associated with 87 
fresh or frozen corneoscleral homologous graft, partial removal approach combined with 88 
cryosurgery, photocoagulation, and strontium-90 plesiotherapy.6,9,10,15,17,20,26-28 The objective of the 89 
present retrospective case series is to evaluate the effectiveness of debulking associated with diode 90 
laser photocoagulation for treatment of LM in dogs and cats. 91 
 92 
MATERIALS AND METHODS  93 
The medical records of 21 patients presented for evaluation of a unilateral pigmented limbal mass, 94 
with a clinical diagnosis of LM and treated with debulking and diode laser photocoagulation at the 95 
Ophthalmology Department of the CVS (Centro Veterinario Specialistico, Rome, Italy) or at the 96 
Long Island Veterinary Specialists (Plainview, Long Island, New York) between 1994 and 2013 97 
were included in this retrospective study. Information recorded from each case included breed, age, 98 
sex, affected eye, presence of lipid keratopathy and location of the lesion in the eye (Table 1). 99 
Veterinary ophthalmologists, primary care veterinarians, and occasionally owners were contacted 100 
via phone for patient follow-up information. 101 
All patients received a complete ophthalmic examination evaluating the menace response, pupillary 102 
light reflex (PLR), dazzle reflex, tear production (Schirmer Tear Test, Schering-Plough Animal 103 
Health, Union, New Jersey), fluorescein staining (HS HAAG-STREIT International Fluorescein, 104 
Switzerland) and intraocular pressure (IOP) (TonoPen Vet, Reichert Inc., Depew, NY). All of the 105 
patients underwent a slit-lamp biomicroscopy (SL-14 Biomicroscope, Kowa Co Ltd, Tokyo, Japan), 106 
gonioscopic evaluation of the iridocorneal angle (ICA) (Koeppe lens, Ocular Instruments, Bellevue, 107 
Washington, USA), and indirect ophthalmoscopy (Omega 500, Heine Optotechnik, Herrsching, 108 
Germany) for the evaluation of the fundus. Ocular ultrasound with a 12.5 MHz. probe (Linscan 109 
Systems Inc., Rolla, Mo, Missouri, USA, or E-Technology unit, Devemport, IA, USA) was 110 
performed for the evaluation of the mass extension within the eye. All patients received a thorough 111 
physical examination prior to general anesthesia (chest radiograph, abdominal ultrasound, and 112 
complete blood work).  113 
Surgery was performed by a board-certified ophthalmologist (AG, JS, ND). Prior to surgery, a drop 114 
of tropicamide+phenylephrine hydrochloride solution (Visumidriatic with Fenilefrina, Visufarma 115 
S.p.a., Rome, Italy) was topically administered. The eyes were subsequently aseptically prepared, 116 
and patients were positioned in dorsal recumbency. Lateral canthotomy was created to allow access 117 
to the globe in all patients except cases 10, 11, 15 and 18, depending on the surgeon’s preference. 118 
The conjunctiva above the melanoma was incised at the limbus (Fig. 1 a), and it was separated from 119 
episclera below to obtain a fornix-based conjunctival flap (Fig. 1 b). After adequate exposure of the 120 
neoplastic tissue, an incision was made using a 64 beaver blade (Eagle Labs, Rancho Cucamonga, 121 
CA, USA) peripherally to the melanoma. If lipid keratopathy was present, it was included in the 122 
excision. A lamellar sclerectomy and keratectomy was performed, including the removal of a 1-2 123 
mm margin of healthy tissue. The excessive bleeding was controlled using an Absorbent Stik (Cell 124 
Sponge) (Becton, Dickinson and Company, Waltham, MA, USA) or with fine wet-field cautery 125 
prior to the ablation of the pigmented base of the melanoma with a diode laser (Iris Medical Diovet 126 
810 nm, Mountain View, CA, USA). A 25 gauge straight endoprobe (Iridex, Mountain View, CA, 127 
USA) was used to destroy any residual pigmentation and was positioned 2 mm from the operated 128 
site (Fig. 1 c). The laser settings are shown in Table 2. Three settings of energy were applied: low 129 
(≤200J), medium (201-399J) and high (≥400J) from 1994 to 2013. After the treatment with the 130 
diode laser, a conjunctival flap was sutured over the surgical site using a 8-0 or 9-0 polyglactin 131 
(Vicryl, Ethicon, Johnson & Johnson Intl, St-Stevens-Wolnwe, Belgium) with a simple interrupted 132 
pattern (Fig. 1 d). A-Cell graft tissue (A-Cell Vet, A-Cell Inc., Jessup, MD) was used in 3 eyes, and 133 
a Biosis membrane (Vet BioSis, Cook Veterinary Products) was used in 1 eye. Instead of the 134 
conjunctival graft A-cell or Biosis material was sutured to the corneoscleral defect using a 8-0 135 
polyglactin (Vicryl, Ethicon, Johnson & Johnson Intl, St-Stevens-Wolnwe, Belgium) (Table. 2). In 136 
all cases, tissue removed from the mass was formalin-fixed and sent for histopathological 137 
examination at the Department of Veterinary Pathology, Hygiene and Public Health, School of 138 
Veterinary Medicine, State University of Milan, Italy.  139 
Post-surgical care consisted in topical ofloxacin 0.3% (for times a day for 21 d; Exocin, Allergan 140 
Spa, Rome, Italy), tropicamide 1% (twice daily for 3 d and once daily for 7 d; Visumidriatic 1%, 141 
Visufarma S.p.a., Rome, Italy), and Fluorometolone Acetate (twice daily for 15 d; Flarex 0.1%, 142 
Alcon Spa, Milano, Italy). Systemic therapy included amoxicillin-clavulanate (12.5 mg/kg, PO, 143 
twice daily; Synulox; Pfizer Animal Health, Sandwich, Kent, UK) and carprofen (2 mg/kg, PO, 144 
once daily; Rimadyl; Pfizer Animal Health, Sandwich, Kent, UK) for 7-10 days. 145 
 146 
Statistical analysis 147 
The Freeman-Halton extension of the Fisher exact test (Freeman and Halton, 1951) was used to 148 
determine whether the total Joule provided could significantly influence recurrence of LM. Three 149 
ranks of energy were considered: low (≤200J), medium (201-399 J) and high (≥400J). Recurrences 150 
were considered only for the first combined surgical treatment. Data were analyzed using 151 
commercial software (IBM SPSS Exact tests, SPSS Inc., Chicago, Ill). Two-sided P values of less 152 
than 0.05 were considered significant. 153 
 154 
RESULTS 155 
A total of 20 canine cases (20 eyes) and 1 feline case (1 eye) met the inclusion criteria, and they 156 
were treated with partial lamellar resection, diode photocoagulation, and conjunctival grafting, A-157 
cell or Biosis grafts for unilateral LM. The mean age at the diagnosis was 5 years, with a range from 158 
7 months to 12 years. Eleven breeds of dogs were represented, including 6 German Shepherds, 1 159 
Dachshund, 1 Labrador Retriever, 1 Golden Retriever, 1 Bull Mastiff, 1 Newfoundland, 1 Irish 160 
Setter, 1 Poodle, 1 Pug, 1 Leonberger and 5 mixed breed dogs. Nine intact females, two spayed 161 
females, seven intact males and two castrated males were included in this series of cases. The only 162 
cat included was an intact Domestic Short Hair (DSH) male. Gonioscopy showed that ICA was 163 
compressed but not invaded. No fundoscopic abnormalities were observed in any of the cases. 164 
Ocular ultrasonography did not show any evidence of extension of the mass into the globe in any of 165 
the eyes. Routine metastasis evaluation (complete blood work, abdominal ultrasound, X-ray chest) 166 
failed to reveal abnormalities precluding surgery. 167 
The right eye (OD) was affected in 13/21 cases, and the left eye (OS) was affected in 8/21 cases. 168 
Tumor localization was dorsolateral in 11/21 eyes, dorsal in 3/21 eyes position, dorsomedial in 2/21 169 
eyes, ventrolateral in 2/21 eyes, ventromedial in 2/21 eyes and medial 1/21 eyes. The most common 170 
location of the mass was the dorsolateral position (11/21; 52%). Corneal endothelial pigmentation 171 
associated with the mass was observed in all patients (21/21), and corneal degeneration (lipid 172 
keratopathy) at the periphery was noted in 7/21 patients (Fig. 2 and 3). The size of the tumor never 173 
exceeded 1/3 of the entire surface of the globe. No other significant ophthalmic findings were noted 174 
in any patient, with the exception of case number 17, which showed negative direct and indirect 175 
PLR, negative swinging flash light test, negative menace response in both eyes and flat 176 
electroretinographic response (RetinoGraphics BPM-200 System, Retinographics, Norwalk, CT, 177 
USA). The dog was diagnosed with sudden acquired retinal degeneration (SARD). 178 
The most remarkable intra-operative complications included moderate to severe scleral hemorrhage 179 
and scleral thinning at the limit of globe perforation.  180 
Histopathological analysis confirmed the diagnosis of limbal melanocytoma. Tumors were 181 
composed of two main cell types, a bland population of spindle or star shaped melanocytes, 182 
characterized by minimal anisocytosis and anisokaryosis and no or occasional mitotic figures and a 183 
second population of large, non-cohesive, round cells with small dense peripheral nuclei and 184 
abundant, melanin laden cytoplasm (Fig. 4). 185 
Follow-up information was obtained by standard re-examination of patients at referral centers at 24 186 
h and 7, 14, 21, 31, 93, 186, and 365 days after the surgery. Long-term follow-up information (≥12–187 
72 months) was collected by clinical re-evaluations in 15/21 pets or completed by a telephone 188 
interview with the owner in 6/21 subjects.  189 
The short-term complications noted during the first two weeks were a slight anterior uveitis and a 190 
moderate corneal edema, both in 21/21 cases (Fig. 2 and 3). In one case (n. 15), necrosis of the 191 
dorsal sclera was noticed. This healed uneventfully with medical therapy over time.  192 
 The long-term complications recorded from the 72 month after surgery showed corneal fibrosis and 193 
corneal pigmentation in 21/21 eyes (Fig. 2, 3) bullous keratopathy in 1/21 eyes (case number 2), 194 
lipid keratopathy in 2/21 eyes, and a mature cataract in 1/21 eyes. There were no recurrences of the 195 
LM in 17/21 eyes. Three of the four recurrences underwent a second similar surgery. Case number 196 
12 underwent successful surgery one month after the first surgical procedure. Case number 2 had 2 197 
recurrences at 6 months of each other. Case number 13 showed a recurrence 1 year after the first 198 
treatment. After the second surgery, no recurrences were observed. Case number 9 had a recurrence 199 
4 years after surgery, but the owner declined any other surgical procedure. In one case (number 8), a 200 
mature cataract was noticed five years after the surgery. Two cases showed a lipid keratopathy after 201 
surgery (numbers 9 and 21) in an eccentric corneal position. 202 
In 19/21 cases, the eyes were visual, comfortable and off all treatment at the time of the final re-203 
examination. The recurrence rate of LMs was significantly lower in patients exposed to high laser 204 
setting then in medium and low group (P=0.04). Tumors treated by laser energy in the range of 201 205 
to 399J were more prone to recurrence. There were 3/5 recurrences with 201-399 J (60%) versus 206 
1/11 with low energy (9%) and 0/6 with high energy (0%).  207 
 208 
DISCUSSION 209 
During the last decades, several techniques have been described for the management of LMs. In 210 
general, surgical approaches to the mass may be into full thickness or partial lamellar resections. In 211 
the case of partial removal, different additional treatments (photocoagulation, cryotherapy and 212 
plesiotherapy) have been suggested to improve effectiveness and to minimize 213 
recurrences.6,9,15,17,18,20-28 Based on this case series, a combined use of debulking and diode laser 214 
photocoagulation was technically easier to perform, minimally invasive and well-tolerated in the 215 
animal, with mild postoperative discomfort and a relatively short anesthesia time. This technique 216 
also showed an acceptable long-term success, as 19/21 eyes (90,47%) were visual 72 months after 217 
the surgery.  218 
The only use of photocoagulation without any surgical reduction of the neoplastic tissue has been 219 
described.10 Removal of the eye was usually reserved for cases of extensive intraocular tumor 220 
growth or in cases of secondary glaucoma or intractable uveitis.15,29-31 Full thickness resection of 221 
LM is the ideal surgical option to minimize any recurrence of the mass,6,13,20-26 but is technically 222 
difficult to perform and requires fresh or frozen corneoscleral homologous graft 6,20 or other tectonic 223 
support material that are not always readily available 21-26 and may be associated with complications 224 
such as intraocular bleeding, blindness, cataract formation, marked uveitis, fibrin in the anterior 225 
chamber and synechiae formation. Martin described the graft to develop a bulge at 34 weeks 226 
postoperatively, which was surgically explored and excised from the scleral base.6 Blogg et al. 227 
reported an iris bulging through the corneal wound at the limbus that required another surgery to 228 
replace the iris.22 A ventromedial distortion of the pupil due to an iris adhesion to the site of the 229 
graft was the main complication in the Lewin study.25 Another possible complication may be the 230 
failure of the neovascularization of the graft, as noticed by Wilkie et al. 7 weeks after surgery.24 231 
Suture dehiscence was reported by Maggio et al.20 All of the eyes in these studies were visual post-232 
operatively, and no recurrence was noted., but the use of the "en bloc" resection is a complex 233 
surgical approach and requires both appropriate surgical skill and the availability of specialized 234 
surgical equipment and donor tissue.  235 
Another surgical approach consists of primary debulking of the mass. This partial removal approach 236 
has been combined with cryosurgery in cats 15,17 and dogs,27 photocoagulation with Nd:YAG laser 237 
and A-Cell bio-scaffold material,18 equine pericardium,28 and strontium-90ß plesiotherapy.9 In the 238 
Donaldson study, 30 dogs were treated with strontium-90 β plesiotherapy. Results revealed a low 239 
rate of recurrence (3%) but an overall complication rate of 53%. This procedure required multiple 240 
general anesthetic episodes and was not readily available due to health and safety implications for 241 
personnel.9 242 
The use of cryotherapy involves the destruction of residual tissue after partial lamellar resection by 243 
low temperatures, which induces crystallization of the cytosol and subsequent cell death. Previous 244 
publications have reported that a temperature of -20°C is able to induce tissue cryonecrosis.15,32 245 
Both nitrous oxide and liquid nitrogen are commonly used in veterinary ophthalmology for 246 
cryotherapy. 15 21 This technique exploits the capacity that freezing has to induce the formation of 247 
crystals inside and outside the cell, which causes water outflow and tissue dehydration. Within a 248 
few hours ischemic necrosis occurs. Melanocytes are particularly cryosensitive due to a high water 249 
content, and corneal melanocytes are as cryosensitive as dermal melanocytes.33,34 The most 250 
common complication of cryotherapy is the development of lipid keratopathy at the treatment site, 251 
but recurrences were not clinically detected in study of Featherstone et al.27 In the present study, 252 
the number of lipid keratopathy after surgery was 2/21 (case number 9 and 21) compared with those 253 
observed before treatment (7/21); only case 21 showed this deposit of crystals before treatment and 254 
the recurrence at one year after. In comparison with the cryotherapy, the use of the diode 255 
photocoagulation in this report has a smaller number of corneal lipidosis as well as extension 256 
neither to exceed the visual axis nor to impair vision, as in the Featherstone et al. report.27 257 
Nevertheless, the low number of cases makes this result not significant and it is difficult to assess 258 
which are the causes of lipid keratopathy that could be linked to other factors (nature of the tumor, 259 
surgery, pre-existing corneal lipidosis, type of graft, or postoperative use of topical steroid). 260 
Photocoagulation represents an effective and available option in destroying melanoma cells. In 261 
veterinary ophthalmology, both the Nd:YAG and diode laser are commonly used for treatment of 262 
glaucoma, uveal pigmented cysts, iris melanoma and retinopexy.10,18,35-38 The diode laser provides 263 
energy in the infrared electromagnetic spectrum (810 nm). At such wavelengths, the main target 264 
chromophore is the melanin. Melanin-rich tissues show a greater tendency to absorb the light that 265 
determines a localized photocoagulative necrosis.39 Diode laser has 1.3 times a superior penetration 266 
rate of tissues compared with the Nd:YAG laser. Consequently, the destructive effect of the diode 267 
laser is achieved with less energy in comparison to the Nd: YAG laser.39 Treatment of LM with the 268 
Nd: YAG laser alone has also been described by Sullivan et al. in dogs and cats.10 This treatment 269 
method was associated with only mild postoperative discomfort, but the recurrence rate was higher 270 
(20%; 3/15) compared with the recurrence rate with the full thickness surgical resection and 271 
grafting techniques. A second treatment was necessary for all three recurrences, and in two eyes, the 272 
tumor did not successfully regress. Additionally, a complication reported with Nd:YAG laser was 273 
corneal lipidosis, which was noted in 3/15 cases, and in one case, was marked compared with the 274 
use of debulking and diode laser photocoagulation (2/21), in which the presumed lipid opacity was 275 
considered to be mild and peripheral. In this presently described technique, the recurrences rate was 276 
4/21: all recurrent LMs were associated at the low and medium laser settings (200J and 201-399J, 277 
respectively) and in only one case was a second treatment not curative (case #2).  278 
In the present study, diode photocoagulation was combined with the lamellar removal of the LM. 279 
Surgical debulking of tumors ensures an adequate tumor exposure to the laser. Partial lamellar 280 
resection was continued until the maximum amount of tumor had been safely excised as judged by 281 
the surgeon. In this case series, globe perforation did not occur. Recurrences (cases 2, 9, 12, 13) 282 
could be caused by a too superficial of a dissection or an insufficient applied energy, as suggested 283 
by the statistical analysis. As shown in Table 2, the number of treated sites increased during the 284 
years. The authors increased the laser power settings to obtain a more intense treatment of the bed 285 
of the debulked mass. In the future, we would advocate the use of higher laser setting (≥400J) to 286 
avoid recurrences. Further investigations should consider the power setting related to the tumor 287 
size. The surgical technique limits the size evaluation of the LM at the time of histopathological 288 
examination due to the partial resection of the neoplasia (provided by the surgeons subjectively). 289 
The inability to perform a complete measurement of the tumor size impair to correlate data about 290 
the power setting vs. mass dimension and any other possible association with recurrences rate. 291 
Loss of vision occurred in 2/21 eyes (cases 2 and 5). In one of these cases (case 5), a mature 292 
cataract that caused blindness was noted 5 years after surgery. In the literature, focal cataractous 293 
changes were observed at equatorial and posterior polar regions of the lens after the use of Nd: YAG 294 
laser37 The exact etiology of the cataract formation in this only case is unknown and may not be due 295 
to the surgical procedure or laser therapy. 296 
Case 2 developed a severe bullous keratopathy after a second treatment with DPC within the first 297 
year of age. The aggressive LM growth in younger dogs it already described by Martin and 298 
Sullivan. 6,10 In this subject, enucleation was suggested to relieve the pain in this blind eye. Because 299 
of the limited number of cases, it is not possible to correlate the age with the tumor growth and the 300 
recurrences but it could be possible that subjects with melanomas very invasive could be more 301 
prone to recurrences and to failure of surgical treatment. However, there are many causes of corneal 302 
edema, including endothelial dystrophy, age-related degeneration, endothelial damage associated 303 
with persistent pupillary membranes (PPMs), mechanical trauma, toxic reactions, anterior uveitis, 304 
endotheliitis, glaucoma, neovascularization, and ulceration.40 Sapienza et al. reported stromal 305 
inflammation and consequent destruction of the normal lamellar corneal composition as an effect of 306 
Nd: YAG laser therapy in 60% of the eyes treated to reduce aqueous humor production36 Repeated 307 
treatments with the use of laser might have predisposed to a more serious corneal inflammation 308 
which could have led to the development of a bullous keratopathy.  309 
Other complications such as slight anterior uveitis, moderate corneal edema and necrosis of the 310 
sclera occurred, but they resolved uneventfully with medical therapy. 311 
The only cat included in this study was operated at 17 years and examined without any recurrence 312 
or metastasis until death at 20 years. Although, the biological behavior of LM is different in cats 313 
than in dogs, in the one feline case that we treated, debulking and diode laser photocoagulation 314 
(DPC) were effective in controlling the disease process. Future studies should be made on a higher 315 
number of cases to confirm the efficacy of this procedure in cats. One report described a 12.5-year-316 
old cat from which the tumor was removed but he died 6 month after initial diagnoses with local 317 
recurrence and apparent distant metastases.16 In another report, metastasis occurred 32 months after 318 
the initial presentation,17 with minimal local invasiveness in the feline patient. Therefore, some 319 
authors have proposed that a better description for this neoplasia in cats may be malignant 320 
melanoma with late metastasis.19 Due to the latency of the melanoma, those patients should be 321 
subjected to complete physical examination, chest radiographs, and abdominal ultrasound every 3-6 322 
months starting 6 months after the first diagnosis.17      323 
Disadvantages of the current surgical technique include the need of the relatively expensive diode 324 
laser and the possible recurrences (additional surgery was required in 4 of 21 eyes (19.0%). Case 325 
number 9 had a recurrence 4 years after surgery, and the owner refused further surgical intervention. 326 
The other 3 dogs with recurrences underwent a further surgery. Of these cases, only one (case 2) 327 
had vision-threatening complications that required an enucleation Futures studies could be 328 
conducted on a larger population using the last laser setting (≥400J) for verify the effective against 329 
the tumor regrowth.  330 
According to the authors‘ knowledge, this is the first report of the combined use of debulking 331 
associated to diode laser photocoagulation in veterinary medicine post-operative long-term follow-332 
up in 6/21 cases were obtained by telephone interview, and the presence of a recurrence was based 333 
on owner judgement and not on a clinical examination. Furthermore, the relatively low number of 334 
cases may have influenced the obtained results. Future studies should include longer and more 335 
consistent updates, a larger population of patients and different laser settings. Ideally, a randomized 336 
controlled trial to compare this technique to previous techniques is welcome.  337 
In conclusion, lamellar debulking with DPC appeared to be an acceptable, simple, and effective 338 
treatment for LMs in dogs and cats and may be considered as a suitable surgical alternative to en-339 
bloc resection and donor grafting especially in cases of extensive melanomas, which are too large 340 
for full thickness resection.  341 
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FIGURE LEGENDS 470 
Figure 1. a) Intra-operative photograph of a limbal melanoma in the dorsolateral limbus (case 4, 471 
OS). The conjunctiva above the melanoma is excised at the limbus with a 64 beaver blade, and the 472 
dissection was completed with Castroviejo scissors. The conjunctival flap was retracted toward the 473 
fornix for an adequate exposure of the neoplastic tissue. b) An incision was made with a 64 beaver 474 
blade peripherally to the melanoma, and a lamellar dissection was completed using both the beaver 475 
blade and Martinez corneal dissector. c) A 25 gauge straight endoprobe was positioned at 2 mm 476 
from the melanoma to deliver laser energy. d) The retracted conjunctival flap was repositioned and 477 
sutured over the surgical site. 478 
 479 
Figure 2. Case # 6. a) Preoperative photograph of a well-defined dorsolateral melanoma involving 480 
50° of the intere limbal circumference with a mild lipid keratophaty. b) The same eye in a 481 
postoperative photograph 1 month after surgey with a moderate corneal fibrosis and 482 
neovascolarization.  483 
 484 
Figure 3. Case # 17. a) Preoperative photograph of a large pigmented mass at the ventromedial 485 
limbus OD. A moderate lipid keratopathy associated at the limbal melanoma is present. b) The same 486 
eye 2 weeks after surgery shows a moderate corneal edema at the periphery of the graft and 487 
abundant neovascularization. c) Two months after surgey, large corneal fibrosis and vascularization 488 
are noted involving approximately half of cornea. 489 
 490 
Figure 4. Histological section of limbal melanocytoma. The tumor is composed of a mixed 491 
population of spindle and large non-cohesive round cells, loaded by abundant intracytoplasmic 492 
melanin. 493 
 494 
 495 
       Table 1. Signalment and clinical 
features 
    
       
Case Sex Age Breed 
lipid 
keratopathy 
Eye Location 
1 F 3 yrs Irish Setter  N OD M 
2 F 7 months German Shepherd  N OS D 
3 M 3 yrs Mixed breed   N OD VL 
4 M 8 yrs German Shepherd  N OD DL 
5 F 6 yrs German Shepherd  N OD DL 
6 M 3 yrs German Shepherd  Y OS DL 
7 F 6 yrs Mixed breed   N OS DL 
8 M 2 yrs Mixed breed   N OS DL 
9 F 6 yrs German Shepherd  N OS DL 
10 MN 3 yrs Golden Retriever Y OD DM 
11 MN 6 yrs Poodle (standard) N OD VL 
12 F 2 yrs German Shepherd  N OD DL 
13 M 4 yrs Newfoundland Y OD DL 
14 F 10 yrs 
Labrador 
Retriever N OD VM 
15 FS 11 yrs Pug N OS DL 
16 F 6 yrs Bull Mastiff Y OS DL 
17 F 8 yrs Dachshund Y OD VM 
18 FS 7 yrs Terrier Mixed Y OS DL 
19 M 17 yrs DSH N OD DM  
20                       F 2 yrs Mixed breed N OD D 
21 M 3 yrs Leonberger Y OD D 
              
F = intact female; M = intact male; FS = female spayed; MN = male neutered; OD = right 
eye; OS = left eye; D = Dorsal; M = Medial; VL = Ventrolateral; DL = Dorsolateral; DM = 
Dorsomedial; VM = Ventromedial: N = no: Y = yes. 
   
        496 
 497 
 498 
 499 
 500 
 501 
 502 
 503 
 504 
 505 
Table 2. Treatment and recurrences 506 
     
C
a
s
e 
Laser setting Total Joules 
delivered 
Surgery Recurrance 
1 1.5W x 1S x 30 sites 45J D, L, CF  no 
2 1.5W x 1S x 30 sites 45J D, L, CF Twice 
3 1.5W x 1S x 30 sites 45J D, L, CF no 
4 1.5W x 1S x 30 sites 45J D, L, CF no 
5 1.5W x 1S x 30 sites 45J D, L, CF no 
6 1.5W x 1S x 30 sites 45J D, L, CF no 
7 1.5W x 1S x 30 sites 45J D, L, CF no,  
8 1.5W x 5S x 30-40 sites 225-300J D, L, CF no 
9 1.5W x 5S x 30-40 sites 225-300J D, L, CF Once 
10 1W x 1S x 34 sites 
1.5W x 1S x 186 sites  
34J 
279J 
D, L, AC (2L) no 
11 1.2W x 1.5S x 72 sites 135J D, L, B (2L) no 
12 1.5W x 5S x 30-40 sites 225-300J D, L, CF Once 
13 1.5W x 5S x 30-40 sites 225-300J D, L, CF Once 
14 1.5W x 9S x 100 sites 1350 J D, L, CF no 
15 1W x 1S x 151 sites 151J  D, L, AC no 
16 1.5W x 9S x 100 sites 1350J D, L, CF no 
17 1.5W x 9S x 100 sites 1350J D, L, CF no 
18 1W x 2S x 59 sites 118J D, L, AC no 
19 1.5W x 1S x 30 sites 45J D,L no 
20 1.5W x 9S x 100 sites  1350J D,L,CF no 
21 1.5W x 9S x 100 sites 1350J D,L,CF no 
 507 
D = Debulking; L = Laser; CF = Conjunctival Flap; AC = A-cell; 2L = 2Layers; B= Biosist. 508 
 509 
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